Database analyses have revealed that FAM20C expression is increased in multiple malignant tumors, including central nervous system tumors, breast cancer (BRC), lung adenocarcinoma, pancreatic tumors, and lymphoma.33 This evidence concerns the gene FAM20C and central nervous system cancer.